Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.
Cascone T, Gold KA, Swisher SG, Liu DD, Fossella FV, Sepesi B, Pataer A, Weissferdt A, Kalhor N, Vaporciyan AA, Hofstetter WL, Wistuba II, Heymach JV, Kim ES, William WN Jr. Cascone T, et al. Among authors: gold ka. Ann Thorac Surg. 2018 Feb;105(2):418-424. doi: 10.1016/j.athoracsur.2017.08.052. Epub 2017 Dec 6. Ann Thorac Surg. 2018. PMID: 29217088 Free PMC article. Clinical Trial.
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer.
Gold KA, Lee JJ, Harun N, Tang X, Price J, Kawedia JD, Tran HT, Erasmus JJ, Blumenschein GR, William WN, Wistuba II, Johnson FM. Gold KA, et al. Oncologist. 2014 Oct;19(10):1040-1. doi: 10.1634/theoncologist.2014-0228. Epub 2014 Aug 28. Oncologist. 2014. PMID: 25170013 Free PMC article. Clinical Trial.
The Myb-p300 Interaction Is a Novel Molecular Pharmacologic Target.
Liu X, Gold KA, Dmitrovsky E. Liu X, et al. Among authors: gold ka. Mol Cancer Ther. 2015 Jun;14(6):1273-5. doi: 10.1158/1535-7163.MCT-15-0271. Epub 2015 May 20. Mol Cancer Ther. 2015. PMID: 25995438 Free PMC article. No abstract available.
56 results